Literature DB >> 19680224

SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation.

Chao Huang1, Yan Han, Yumei Wang, Xuxu Sun, Shan Yan, Edward T H Yeh, Yuying Chen, Hui Cang, Hui Li, Guiying Shi, Jinke Cheng, Xueming Tang, Jing Yi.   

Abstract

The physiological function of Sentrin/SUMO-specific proteases (SENPs) remains largely unexplored, and little is known about the regulation of SENPs themselves. Here, we show that a modest increase of reactive oxygen species (ROS) regulates SENP3 stability and localization. We found that SENP3 is continuously degraded through the ubiquitin-proteasome pathway under basal condition and that ROS inhibit this degradation. Furthermore, ROS causes SENP3 to redistribute from the nucleoli to the nucleoplasm, allowing it to regulate nuclear events. The stabilization and redistribution of SENP3 correlate with an increase in the transcriptional activity of the hypoxia-inducing factor-1 (HIF-1) under mild oxidative stress. ROS-enhanced HIF-1 transactivation is blocked by SENP3 knockdown. The de-SUMOylating activity of SENP3 is required for ROS-induced increase of HIF-1 transactivation, but the true substrate of SENP3 is the co-activator of HIF-1 alpha, p300, rather than HIF-1 alpha itself. Removing SUMO2/3 from p300 enhances its binding to HIF-1 alpha. In vivo nude mouse xenografts overexpressing SENP3 are more angiogenic. Taken together, our results identify SENP3 as a redox sensor that regulates HIF-1 transcriptional activity under oxidative stress through the de-SUMOylation of p300.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19680224      PMCID: PMC2750016          DOI: 10.1038/emboj.2009.210

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  73 in total

Review 1.  Ubiquitin-like proteins: new wines in new bottles.

Authors:  E T Yeh; L Gong; T Kamitani
Journal:  Gene       Date:  2000-05-02       Impact factor: 3.688

2.  A novel superoxide-producing NAD(P)H oxidase in kidney.

Authors:  A Shiose; J Kuroda; K Tsuruya; M Hirai; H Hirakata; S Naito; M Hattori; Y Sakaki; H Sumimoto
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

3.  A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase.

Authors:  T Nishida; H Tanaka; H Yasuda
Journal:  Eur J Biochem       Date:  2000-11

4.  Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing.

Authors:  N S Chandel; D S McClintock; C E Feliciano; T M Wood; J A Melendez; A M Rodriguez; P T Schumacker
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

Review 5.  SUMO under stress.

Authors:  Denis Tempé; Marc Piechaczyk; Guillaume Bossis
Journal:  Biochem Soc Trans       Date:  2008-10       Impact factor: 5.407

6.  Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha.

Authors:  P J Kallio; K Okamoto; S O'Brien; P Carrero; Y Makino; H Tanaka; L Poellinger
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

7.  Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: the mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1.

Authors:  Xin-zhi Huang; Jie Wang; Chao Huang; Yu-ying Chen; Gui-ying Shi; Qing-shen Hu; Jing Yi
Journal:  Cancer Biol Ther       Date:  2007-12-21       Impact factor: 4.742

8.  Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3.

Authors:  Mei-Ling Kuo; Willem den Besten; Mary C Thomas; Charles J Sherr
Journal:  Cell Cycle       Date:  2008-11-04       Impact factor: 4.534

9.  Mitochondrial reactive oxygen species trigger hypoxia-induced transcription.

Authors:  N S Chandel; E Maltepe; E Goldwasser; C E Mathieu; M C Simon; P T Schumacker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

10.  The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing.

Authors:  Markus Haindl; Thomas Harasim; Dirk Eick; Stefan Muller
Journal:  EMBO Rep       Date:  2008-02-08       Impact factor: 8.807

View more
  86 in total

1.  The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy.

Authors:  Petr Dmitriev; Andrei Petrov; Eugenie Ansseau; Luiza Stankevicins; Sébastien Charron; Elena Kim; Tomas Jan Bos; Thomas Robert; Ahmed Turki; Frédérique Coppée; Alexandra Belayew; Vladimir Lazar; Gilles Carnac; Dalila Laoudj; Marc Lipinski; Yegor S Vassetzky
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

Review 2.  SUMO rules: regulatory concepts and their implication in neurologic functions.

Authors:  Mathias Droescher; Viduth K Chaugule; Andrea Pichler
Journal:  Neuromolecular Med       Date:  2013-08-30       Impact factor: 3.843

Review 3.  Emerging roles of SUMO modification in arthritis.

Authors:  Dongyao Yan; Francesca J Davis; Andrew D Sharrocks; Hee-Jeong Im
Journal:  Gene       Date:  2010-07-11       Impact factor: 3.688

4.  Distribution and paralogue specificity of mammalian deSUMOylating enzymes.

Authors:  Nagamalleswari Kolli; Jowita Mikolajczyk; Marcin Drag; Debaditya Mukhopadhyay; Nela Moffatt; Mary Dasso; Guy Salvesen; Keith D Wilkinson
Journal:  Biochem J       Date:  2010-09-01       Impact factor: 3.857

5.  A fine-tuning mechanism underlying self-control for autophagy: deSUMOylation of BECN1 by SENP3.

Authors:  Kejia Liu; Chu Guo; Yimin Lao; Jie Yang; Fei Chen; Yuzheng Zhao; Yi Yang; Jie Yang; Jing Yi
Journal:  Autophagy       Date:  2019-08-02       Impact factor: 16.016

6.  p53 sumoylation: mechanistic insights from reconstitution studies.

Authors:  Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  Epigenetics       Date:  2009-10-09       Impact factor: 4.528

7.  Identification and characterization of a new chemotype of noncovalent SENP inhibitors.

Authors:  Ikenna G Madu; Andrew T Namanja; Yang Su; Steven Wong; Yi-Jia Li; Yuan Chen
Journal:  ACS Chem Biol       Date:  2013-05-01       Impact factor: 5.100

8.  Silencing of the JNK pathway maintains progesterone receptor activity in decidualizing human endometrial stromal cells exposed to oxidative stress signals.

Authors:  Beatriz Leitao; Marius C Jones; Luca Fusi; Jenny Higham; Yun Lee; Masashi Takano; Tomoko Goto; Mark Christian; Eric W-F Lam; Jan J Brosens
Journal:  FASEB J       Date:  2009-12-21       Impact factor: 5.191

9.  Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90.

Authors:  Shan Yan; Xuxu Sun; Binggang Xiang; Hui Cang; Xunlei Kang; Yuying Chen; Hui Li; Guiying Shi; Edward T H Yeh; Beilei Wang; Xiangrui Wang; Jing Yi
Journal:  EMBO J       Date:  2010-10-05       Impact factor: 11.598

10.  Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.

Authors:  Wei Yang; Liangli Wang; Gabriele Roehn; Robert D Pearlstein; Francis Ali-Osman; Hongjie Pan; Roland Goldbrunner; Matthew Krantz; Christoph Harms; Wulf Paschen
Journal:  Cancer Sci       Date:  2012-11-28       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.